E. Begier

Impact of SARS-CoV-2 infective exacerbation of chronic obstructive pulmonary disease on clinical outcomes in a prospective cohort study of hospitalised adults

L. Danon, N. Maskell, B. Gessner, 2023, Journal of the Royal Society of Medicine.

Severity of Omicron (B.1.1.529) and Delta (B.1.617.2) SARS-CoV-2 infection among hospitalised adults: A prospective cohort study in Bristol, United Kingdom

L. Danon, N. Maskell, B. Gessner, 2022, The Lancet Regional Health - Europe.

Impact of 13-valent pneumococcal conjugate vaccine on laboratory-confirmed pneumococcal meningitis and purulent meningitis among children ˂5 years in Cameroon, 2011–2018

S. Madhi, B. Gessner, E. Begier, 2021, PloS one.

Pneumococcal serotypes in adults hospitalized with community-acquired pneumonia in Greece using urinary antigen detection tests: the EGNATIA study, November 2017 – April 2019

A. Liapikou, B. Gessner, H. Milionis, 2022, Human vaccines & immunotherapeutics.

The Landscape of Lyme Borreliosis Surveillance in Europe

B. Gessner, A. Vyse, J. H. Stark, 2023, Vector borne and zoonotic diseases.

A Retrospective Database Study of Lyme Borreliosis Incidence in Poland from 2015 to 2019: A Public Health Concern

B. Gessner, A. Vyse, M. Dzingina, 2023, Vector borne and zoonotic diseases.